1American Diabetes Association (2002) Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 23, 43–46.
2Cani, PD, Daubioul, CA, Reusens, B, Remacle, C, Catillon, G & Delzenne, NM (2005) Involvement of endogenous glucagon-like peptide-1 (7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. J Endocrinol 185, 457–465.
3Delzenne, NM, Cani, PD, Daubioul, C & Neyrinck, AM (2005) Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr 93, S157–S161.
4Kok, NN, Morgan, LM, Williams, CM, Roberfroid, MB, Thissen, J-P & Delzenne, NM (1998) Insulin, glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide and insulin-like growth factor I as putative mediators of the hypolipidemic effect of oligofructose in rats. J Nutr 128, 1099–1103.
5Hay, CW, Sinclair, EM, Bermano, G, Durward, E, Tadayyon, M & Docherty, K (2005) Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP- responsive elements that lie upstream and downstream of the transcription start site. J Endocrinol 186, 353–365.
6Drucker, DJ, Philippe, J, Mojsov, S, Chick, WL & Habener, JF (1987) Glucagon-like peptide 1 stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Nat Acad Sci 84, 3434–3438.
7Cani, PD, Knauf, C, Iglesias, MA, Drucker, DJ, Delzenne, NM & Burcelin, R (2006) Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55, 1484–1490.
8López, MG, Mancilla-Margalli, NA & Mendoza-Díaz, G (2003) Molecular structures of fructans from Agave tequilana Weber var. azul. J Agric Food Chem 51, 7835–7840.
9Mancilla-Margalli, NA & López, MG (2006) Water-soluble carbohydrates and fructan structure patterns from Agave and Dasylirion species. J Agric Food Chem 54, 7832–7839.
10Gibson, GR & Wang, X (1994) Bifidogenic properties of different types of fructo-oligosaccharides. Food Microbiol 11, 491–498.
11López, MG & Urías-Silvas, JE (2007) Agave fructans as prebiotics. In Advances in Fructooligosaccharides Research [Shiami, N, Benkeblia, N and Ondera, S, editors]. Kerala, India:Research Signpost.
12Cani, PD, Dewever, C & Delzenne, NM (2004) Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr 92, 521–526.
13Folch, J, Lees, M & Sloane-Stanley, G (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226, 497–509.
14Bradford, M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248–254.
15Chen, H-L, Sheu, WH-H, Tai, T-S, Liaw, Y-P & Chen, Y-C (2003) Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects – a randomized double-blind trial. J Am Coll Nutr 22, 36–42.
16Chandalia, M, Abhimanyu, G, Lutjohann, D, von Bergmann, K, Grundy, SM & Brinkley, LJ (2000) Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. New Eng J Med 342, 1392–1398.
17Vuksan, V, Sievenpiper, JL, Owen, R, et al. (2000) Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome. Diabetes Care 23, 9–14.
18Anderson, JW, Allgood, LD, Turner, J, Oeltgen, PR & Daggy, BP (1999) Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia. Am J Clin Nutr 70, 466–473.
19Groop, P-H, Aro, A, Stenman, S & Groop, L (1993) Long-term effects of guar gum in subjects with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 58, 513–518.
20Tappenden, KA, Albin, DM, Bartholome, AL & Mangian, HF (2003) Glucagon-like peptide-2 and short chain fatty acids: a new twist to an old story. J Nutr 133, 3717–3720.
21Massimino, SP, McBurney, MI, Field, CJ, Thomson, ABR, Keelan, M, Hayek, MC & Sunvold, GD (1998) Fermentable dietary fiber increases GLP-1 secretion and improves glucose homeostasis despite increased intestinal glucose transport capacity in healthy dogs. J Nutr 128, 1786–1793.
22Reimer, RA & McBurney, MI (1996) Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and prosprandial secretion of glucagon-like peptide-1 and insulin in rats. Endocrinology 137, 3948–3956.
23Meier, JJ, Gallwitz, B, Schmidt, WE & Nauck, MA (2002) Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives. Eur J Pharmacol 440, 269–279.
24Holz, GG, Kuhtreiber, WM & Habener, JF (1993) Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1 (7-37). Nature 361, 362–365.
25Nauck, MA, Niedereichholz, U, Ettler, R, Holst, JJ, Orskov, C, Ritzel, R & Schmiegel, WH (1997) Glucagon-like peptide 1 inhibition of gastric emptying outweight its insulinotropic effects in healthy humans. Am J Physiol – Endocrinol Met 273, E981–E988.
26Turton, MD, O'Shea, D, Gunn, I, Beak, SA, Edward, CMB & Meeran, K (1996) A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379, 69–72.
27Komatsu, R, Matsuyama, T, Namba, M, Watanabe, N, Itoh, H, Kono, N & Tarui, S (1989) Glucagonostatic and insulinotropic action of glucagon-like peptide 1 (7-36)-amide. Diabetes 38, 902–905.
28Trautwein, EA, Rieckhoff, D & Erbersdobler, HF (1998) Dietary inulin lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profile in Hamsters. J Nutr 128, 1937–1943.
29Campbell, JM, Fahey, GC & Wolf, BW (1997) Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J Nutr 127, 130–136.
30Delzenne, NM, Aertssens, J, Verplaetse, H, Roccaro, M & Roberfroid, M (1995) Effect of fermentable fructo-oligosaccharides on mineral, nitrogen, and energy digestive balance in the rat. Life Sci 57, 1579–1587.
31Ji, H & Friedman, MI (2003) Fasting plasma triglyceride levels and fat oxidation predicts dietary obesity in rats. Physiol Behav 78, 767–772.
32Demonty, I, Lamarche, B, Deshaies, Y & Jacques, H (2002) Role of soy isoflavones in the hypotriglyceridemic effect of soy protein in the rat. J Nutr Biochem 13, 671–677.
33Delzenne, NM & Kok, NN (1999) Biochemical basis of oligofructose-induced hypolipidemia in animal models. J Nutr 129, 1467S–1470S.
34Kok, N, Roberfroid, M, Robert, A & Delzenne, N (1996) Involvement of lipogenesis in the lower VLDL secretion induced by oligofructose in rats. Br J Nutr 76, 881–890.
35Hillgartner, FD, Salati, LM & Goodridge, AG (1995) Physiological and molecular mechanism involved in nutritional regulation of fatty acid synthesis. Physiol Rev 75, 47–76.
36Delzenne, NM (2003) Oligosaccharides: state of the art. Proc Nutr Soc 62, 177–182.
37Demigné, C, Rémésy, C & Morand, C (1999) Short chain fatty acids. In Colonic Microbiota, Nutrition and Health, pp. 55–69 [Gibson, G and Roberfroid, M, editors]. Dordrecht, The Netherlands: Kluwer Academic Publisher.
38Kok, N, Taper, H & Delzenne, N (1998) Oligofructose modulates lipid metabolim alterations induced by a fat-rich diet in rats. J Appl Toxicol 18, 47–53.
39Daubioul, C, Rousseau, N, Demeure, R, Gallez, B, Taper, H, Declercq, B & Delzenne, N (2002) Dietary fructans, but not cellulose, decrease triglyceride accumulation in the liver of obese Zucker fa/fa rats. J Nutr 132, 967–973.
40Reimer, RA, Thomson, ABR, Rajotte, RV, Basu, TK, Ooraikul, B & McBurney, MI (1997) A physiological level of rhubarb fiber increases proglucagon gene expression and modulates intestinal glucose uptake in rats. J Nutr 127, 1923–1928.
41Cani, PD, Hoste, S, Guiot, Y & Delzenne, NM (2007) Dietary non digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr 98, 32–37.
42Tappenden, KA, Drozdowski, LA, Thomson, ABR & McBurney, MI (1998) Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats. Am J Clin Nutr 68, 118–125.
43Tappenden, KA & McBurney, MI (1998) Systemic short-chain fatty acids rapidily alter gastrointestinal structure, function, and expression of early response genes. Did Dis Sci 43, 1526–1536.
44Zhou, J, Hegsted, M, McCutcheon, KL, Keenan, MJ, Xi, X, Raggio, AM & Martin, RJ (2006) Peptide YY and proglucagon mRNA expression patterns and regulation in the gut. Obesity 14, 683–689.
45Flint, A, Raben, A, Astrup, A & Holst, JJ (1998) Glucagon-like peptide-1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101, 515–520.
46Piche, T, des Varannes, SB, Sacher-Huvelin, S, Holst, JJ, Cuber, JC & Galmiche, JP (2003) Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology 124, 894–902.
47Cani, PD, Joly, E, Horsmans, Y & Delzenne, NM (2006) Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr 60, 567–572.